Ultrgenyx shares down as much as 9 % due to 3 cases of lower limb weakness, considered a serious side effect. They all recovered but trial results not being received very well .
Ann: Completion of enrolment in Neuren's Angelman P2 trial, page-44
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.59 |
Change
-0.610(4.30%) |
Mkt cap ! $1.710B | |||
| Open | High | Low | Value | Volume |
| $13.88 | $13.91 | $13.29 | $9.273M | 686.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 232 | $13.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.59 | 18 | 2 |
View Market Depth
| Last trade - 14.46pm 08/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |